Internet-Based Program for Colorectal Cancer
(CRCweb Trial)
Trial Summary
What is the purpose of this trial?
This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a web-based program to help manage symptoms for colorectal cancer patients receiving chemotherapy.
What data supports the effectiveness of the treatment Web-Based Dyadic Intervention for Colorectal Cancer?
Research shows that web-based psychosocial interventions can improve self-efficacy (confidence in managing one's health), reduce anxiety and depression, and enhance the quality of life for colorectal cancer patients. Additionally, these interventions help both patients and their caregivers cope better with cancer together.12345
Is the Internet-Based Program for Colorectal Cancer safe for humans?
How is the Web-Based Dyadic Intervention for Colorectal Cancer different from other treatments?
The Web-Based Dyadic Intervention for Colorectal Cancer is unique because it focuses on supporting both patients and their caregivers together, using an online platform to help them cope with cancer as a unit. This approach is different from traditional treatments that typically focus only on the patient, and it combines online and in-person support to enhance the quality of life and self-management for both parties.14578
Research Team
Yufen Lin, PhD, RN
Principal Investigator
Emory University Hospital/Winship Cancer Institute
Eligibility Criteria
This trial is for adults over 18 with colorectal cancer who are currently undergoing chemotherapy and have a life expectancy of more than 12 months. Participants must experience at least two psychoneurological symptoms, have a primary caregiver willing to join the study, be fluent in English, and have internet access. Those with severe conditions or very poor performance status (Karnofsky Scale <50) cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Patients and caregivers attend a CRCweb intervention to manage psychoneurological symptoms
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Web-Based Dyadic Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Oncology Nursing Society
Collaborator